Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Rebif approval application
12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia.
Gastro Effects Dog Oral MS Drug Tecfidera
Novartis announces Russian regulatory approval for Gilenya®, a once-daily oral multiple sclerosis therapy and first in a new class
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate.
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.
PML in a patient treated with dimethyl fumarate from a compounding pharmacy.
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis.
Treatment Burden and Chronic Illness: Who is at Most Risk?
Hydrogen-rich water improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.
Multiple Sclerosis: An Update.
Rare onset symptoms in multiple sclerosis.
Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis.
Keystone Symposium: T Cells: Regulation and Effector Function
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.
10 years of interferon beta-1b (Beta feron therapy.
Induction of a Unique Isoform of the NCOA7 Oxidation Resistance Gene by Interferon β-1b.
Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.
Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
Is the MS community ready to promote brain health? Reception and Symposium
A Combination Trial of Copaxone plus Estriol in Relapsing Remitting Multiple Sclerosis
Motor skill learning requires active central myelination.

Pages